drugset / Trial / NCT01428037

Safety and Efficacy Study of Vaginal Misoprostol for Cervical Ripening and Induction of Labor

NCT01428037

Phase 3 Completed 225 enrolled Regenex Pharmaceutical, China
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to estimate the efficacy and safety of the 25mcg vaginal misoprostol for cervical ripening and induction of labour.

Timeline

Start
2012-03
Primary completion
2013-01
Completion
2013-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Misoprostol Other / unclassified 25 ug Other

Indications